BAOTAI PHARMACEUTICAL

Two decades in pharmaceuticals, empowering global health

Committed to offering global clients full industrial chain product solutions and technology transfer services covering human medicines, veterinary drugs, medical devices & supplies, and pharmaceutical equipment.

View More

BAOTAI PHARMACEUTICAL

Committed to full-industry-chain products and R&D services in the pharmaceutical sector.
View More

BAOTAI PHARMACEUTICAL

Two decades in pharmaceuticals

Empowering global health

Global Quality Products

Ceftazidime and Avibactam Sodium for Injection

Ingredients: A combination antibiotic consisting of two active components: ceftazidime and avibactam.

Cefoperazone Sodium and Sulbactam Sodium for Injection

Ingredients: A combined antibiotic consisting of two active components: cefoperazone sodium and sulbactam sodium.

Amoxicillin Sodium and Clavulanate Potassium for Injection

Ingredients: A combination antibiotic containing two active ingredients: amoxicillin sodium and clavulanate potassium.

Ampicillin Sodium and Sulbactam Sodium for Injection

Ingredients: Compound preparation containing two active components: ampicillin sodium and sulbactam sodium

Piperacillin Sodium and Tazobactam Sodium(4:1)for Injection

Ingredients: Compound preparation consisting of two active components: piperacillin sodium and tazobactam sodium.

Aztreonam for Injection

Description: This product is white or off-white powder or loose lumps.

Meropenem For Injection

Description: White to pale yellowish-white or light yellow crystalline powder

Metronidazole Injection

Ingredients: Compound preparation containing metronidazole and sodium chloride.

We bridge premium pharma products

to global emerging markets.

Exhibition
Exhibition
Exhibition
Exhibition
Exhibition
Exhibition

Global Vision

Core Strength


Endowed with profound industry heritage and forward-looking global layout, Baotai Pharma serves as the vital bridge linking China's premium pharmaceutical capacity to emerging markets across Asia, Africa and Latin America.

View More
factory
factory
factory
factory
factory
factory

BAOTAI

(HANGZHOU)

PHARMACEUTICAL

Two decades in pharma, empowering global health

Rooted in pharma for decades and globally visionary, Baotai Pharma bridges China’s premium pharma capacity with emerging markets across Asia, Africa and Latin America.

View More
BAOTAI PHARMACEUTICAL

2000 — 2016

Since 2000, we have specialized in pharmaceutical international trade with profound regulatory expertise and global network resources. Officially incorporated in 2016, we have entered a new era of standardized and large-scale operation.

BAOTAI PHARMACEUTICAL

2018 - 2020

By the end of 2018, the company completed a strategic upgrade with forward-looking vision, shifting fully from the generic drug market to high-standard GMP markets. It focuses on high-barrier therapeutic areas including cardiovascular, antiviral and anti-tumor sectors, achieving a qualitative leap from product export to technology empowerment.

BAOTAI PHARMACEUTICAL

2020 - NOW

In 2020, the headquarters settled in Hangzhou. Leveraging the Yangtze River Delta’s talent and supply chain advantages, it set up offices in Linping (Hangzhou) and Chengdu. In 2023, annual business volume exceeded USD 7.5 million, demonstrating strong growth resilience.

Blog & Event

Insights from Our Blogs


Cooperative partners include well-known pharmaceutical groups with advanced production technology, strict quality inspection mechanisms and abundant production capacity.


In accordance with global market demand distribution and regional policy characteristics, we define the Philippines and Uzbekistan as two strategic core markets to radiate surrounding areas.


We adhere to customer-oriented service philosophy and deliver full life cycle one-stop customized supporting services running through the whole cooperation process.

Get Free Product Quotes

Fill in your email, we will contact you promptly within one business day to resolve the issue you raised as soon as possible.

SUBMIT